Hypertension in Wilms tumor

Pediatr Nephrol. 2024 Jan;39(1):15-24. doi: 10.1007/s00467-023-06011-y. Epub 2023 May 13.

Abstract

Wilms tumor (WT) represents over 90% of all pediatric kidney tumors. Children with WT often present acutely with hypertension which resolves in the short term after nephrectomy. However, WT survivors have increased long-term risk of hypertension, primarily due to decreased nephron mass after nephrectomy, with additional insults from possible exposure to abdominal radiation and nephrotoxic therapies. The diagnosis of hypertension may be improved by ambulatory blood pressure monitoring (ABPM), as several recent single-center studies have shown a substantial proportion of WT survivors with masked hypertension. Current gaps in knowledge include determining which WT patients may benefit from routine screening with ABPM, correlation of casual and ABPM parameters with cardiac abnormalities, and longitudinal assessment of cardiovascular and kidney parameters in relation to appropriate treatment of hypertension. This review aims to summarize the most recent literature on hypertension presentation and management at the time of WT diagnosis as well as the long-term hypertension risk and impact on kidney and cardiovascular outcomes in WT survivors.

Keywords: Cardiovascular disease; Chronic kidney disease; Hypertension; Survivorship; Wilms tumor.

Publication types

  • Review

MeSH terms

  • Blood Pressure
  • Blood Pressure Monitoring, Ambulatory
  • Child
  • Glomerular Filtration Rate / physiology
  • Humans
  • Hypertension* / diagnosis
  • Hypertension* / epidemiology
  • Hypertension* / etiology
  • Kidney Neoplasms* / diagnosis
  • Kidney Neoplasms* / therapy
  • Wilms Tumor* / complications
  • Wilms Tumor* / diagnosis
  • Wilms Tumor* / therapy